Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on August 9, 2023. The filing serves to announce the Company's financial results for the period ended June 30, 2023, and provides an update on recent corporate events. The report includes a press release and a letter to stockholders as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached Exhibits 99.1 and 99.2, which are not included in the source text.
Material Changes
The filing indicates that material updates regarding financial results and corporate events were issued on August 9, 2023. Specific details regarding changes versus the prior comparable period are not present in the cover page text.
Guidance, Outlook, and Risks
The Company issued a letter to stockholders and a press release containing an update on recent corporate events. The filing explicitly states that the information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act and does not constitute an admission of material information under Regulation FD. The Company does not assume an obligation to update this information in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific financial results for the period ended June 30, 2023.
- Review Exhibit 99.2 (Letter to Stockholders) for details on recent corporate events and strategic updates.
- Verify the status of the Company's outstanding debt securities: 8.625% Senior Notes due 2026 (HROWL) and 11.875% Senior Notes due 2027 (HROWM).
- Confirm whether the "recent corporate events" mentioned impact the Company's liquidity or operational continuity.